The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of the Oncotype DX genomic prostate score for risk stratification in prostate cancer patients considered candidiates for active surveilance.
Ganesh K Kartha
No relevant relationships to disclose
Yaw Nyame
No relevant relationships to disclose
Eric A. Klein
Consultant or Advisory Role - Genomic Health; Metamark Genetics
Honoraria - Genomic Health
Research Funding - GenomeDx Biosciences